Advanced Vaginal Adenosquamous Carcinoma: Clinical Trials

2 trials for Advanced Vaginal Adenosquamous Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 31Active not recruiting 1

Follow Advanced Vaginal Adenosquamous Carcinoma: new trials by email Literature Review of Advanced Vaginal Adenosquamous Carcinoma trials Research Report on Advanced Vaginal Adenosquamous Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
Biospecimen Collection, Brachytherapy, Cisplatin - Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)212019-09-182026-07-31
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
Brachytherapy, Cisplatin, External Beam Radiation Therapy - Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma
Phase 3Active not recruitingNational Cancer Institute (NCI)4502016-05-102026-10-22

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Vaginal Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Vaginal Diseases (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (2)  ·  3-aminopyridine-2-carboxaldehyde thiosemicarbazone (2)  ·  Brachytherapy (2)  ·  Cisplatin (2)  ·  Congresses as Topic (2)  ·  Platinum (2)  ·  Radiation (2)  ·  Radiotherapy, Intensity-Modulated (2)  ·  Fluorodeoxyglucose F18 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Radiotherapy (1)  ·  Specimen Handling (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

United States (2)  ·  Canada (1)  ·  Puerto Rico (1)

Top investigators

Charles A Leath (1)  ·  Sarah E Taylor (1)

Results publications

PMID 29868473, PMID 31681600, PMID 39673591

NIH funding

U10CA180868 (1), UM1CA186690 (1)